MICHAEL E GRUIDL
Medical Practice at Silverhill Dr, Tampa, FL
License number
Florida 45534
Issued Date
Aug 20, 2013
Effective Date
Aug 20, 2013
Expiration Date
Aug 31, 2018
Category
Health Care
Type
Clinical Laboratory Personnel
Address
Address
16508 Silverhill Dr, Tampa, FL 33624
Phone
(813) 265-0051
Professional information
Entomopoxvirus Expression System
US Patent:
6410221, Jun 25, 2002
Filed:
Aug 9, 1999
Appl. No.:
09/370861
Inventors:
Richard W. Moyer - Gainesville FL
Richard L. Hall - Gainesville FL
Michael E. Gruidl - Tampa FL
Yi Li - Gainesville FL
Richard L. Hall - Gainesville FL
Michael E. Gruidl - Tampa FL
Yi Li - Gainesville FL
Assignee:
University of Florida Research Foundation, Inc. - Gainesville FL
International Classification:
C12Q 168
US Classification:
435 5, 4353201, 4352351, 435 691, 435 6, 435325, 435348, 536 231, 536 232, 536 234, 536 2372, 536 241, 536 243
Abstract:
The subject invention pertains to novel Entomopoxvirus (EPV) polynucleotide sequences free from association with other viral sequences with which they are naturally associated, recombinant polynucleotide vectors containing the sequences, recombinant viruses containing the sequences, and host cells infected with the recombinant viruses are provided herein, as well as methods for use thereof in the expression of heterologous proteins in both insect and mammalian host cells.
Entomopoxvirus Expression System
US Patent:
5935777, Aug 10, 1999
Filed:
Oct 17, 1995
Appl. No.:
8/544332
Inventors:
Richard W. Moyer - Gainesville FL
Richard L. Hall - Gainesville FL
Michael E. Gruidl - Tampa FL
Yi Li - Gainesville FL
Richard L. Hall - Gainesville FL
Michael E. Gruidl - Tampa FL
Yi Li - Gainesville FL
Assignee:
University of Florida Research Foundation, Inc. - Gainesville FL
International Classification:
C12Q 170, C07H 2104, C12P 2100, C12N 1586
US Classification:
435 5
Abstract:
The subject invention pertains to novel Entomopoxvirus (EPV) polynucleotide sequences free from association with other viral sequences with which they are naturally associated, recombinant polynucleotide vectors containing the sequences, recombinant viruses containing the sequences, and host cells infected with the recombinant viruses are provided herein, as well as methods for use thereof in the expression of heterologous proteins in both insect and mammalian host cells.